Editor’s Note We all have heard about the value of the  Mediterranean Diet for our CV patients. In addition clinicians often advise patients to use this food plan to reduce LDL, weight and glucose levels. What is it about these food choices that cause improvements in CV outcomes? This week our …

Dr. Paresh Dandona, Professor of Medicine and Chief of the Division of Endocrinology, Diabetes and Metabolism at the University of Buffalo, The State University of New York, joins Associate Medical Editor Joy Pape in a discussion at the 2015 ADA Sessions in Boston regarding highlights of his presentation, "GLP-1 Receptor Agonists as Adjunctive Treatment in Type 1 Diabetes."

Always considered the mainstay of dyslipidemia management, significant reductions in LDL levels are difficult to achieve with diet except with long-term adherence to a regimen that most Western people would consider punitive.

Twice I have had patients re-admit to inpatient care after repetition of DKA within 48 hours of last admission. Clearly, the patients were not receiving insulin.

In this week's Homerun Slides, lessons from the ORIGIN Trial and insulin effects on human islet function.